HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Merali, S. Articles by Clarkson, A. B. Search for Related Content PubMed PubMed Citation Articles by Merali, S. Articles by Clarkson, A. B., Jr. Social Bookmarking                      What's this?

J Biol Chem, Vol. 275, Issue 20, 14958-14963, May 19, 2000

S-Adenosylmethionine and Pneumocystis carinii^*

Salim Merali, Diana Vargas, Matthew Franklin, and Allen B. Clarkson Jr.

From the Department of Medical and Molecular Parasitology, New York University School of Medicine, New York, New York 10010

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

We previously reported that S-adenosylmethionine (AdoMet), a key molecule in methylation reactions and polyamine biosynthesis, enhances axenic culture of the AIDS-associated opportunistic fungal pathogen Pneumocystis carinii. Here we report that AdoMet is absolutely required for continuous growth. Two transporters are present, one high affinity, K_m = 4.5 µM, and one low affinity, K_m = 333 µM. The physiologically relevant high affinity transporter has a pH optimum of 7.5 and no related natural compounds compete for uptake. Transport is 98% inhibited at 4 °C, 24% inhibited by 20 mM sodium azide, and 95% inhibited by the combination of 20 mM sodium azide and 1 mM salicylhydroxamic acid; thus transport is active and dependent on both a cytochrome chain and an alternative oxidase. In vitro, AdoMet is used at a rate of 1.40 × 10⁷ molecules cell¹ min¹. AdoMet synthetase activity was not detected by a sensitive radiolabel incorporation assay capable of detecting 0.1% of the activity in rat liver. In addition, the AdoMet plasma concentration of rats is inversely correlated with the number of P. carinii in the lungs. These findings demonstrate that P. carinii is an AdoMet auxotroph. The uptake and metabolism of this compound are rational chemotherapeutic targets.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Pneumocystis carinii is a fungus that causes P. carinii pneumonia (PCP)¹ in people with AIDS, patients undergoing cancer chemotherapy, and others with conditions causing severe immunosuppression. Although the frequency of PCP in HIV-infected persons has decreased dramatically over the last 8 years, due first to widespread prophylaxis against PCP and more recently to the reduced immunosuppression brought on by improved anti-HIV therapy, PCP remains common in AIDS patients. Treatment for PCP is less than ideal with frequent severe side effects from the two most effective drugs, pentamidine and the combination of trimethoprim and sulfamethoxazole (cotrimoxazole, TMP-SMZ) (1). The mortality rate also remains high (21.5%) (2). Beyond the importance of P. carinii as a pathogen, it is also an unusual and interesting fungus for which most basic metabolic processes are unknown.

S-Adenosyl-L-methionine (AdoMet) plays a pivotal role in the physiology of all cells, both as methyl donor in myriad of biological and biochemical events and as a precursor of polyamines. About 95% of AdoMet is used for transmethylation reactions in which the N-methyl group of the methionine moiety is transferred to large molecules such as proteins, complex lipids, and DNA or to small molecules to form lecithin, regenerate methionine, etc. (3). The remaining 2-5% of AdoMet is decarboxylated to become the aminopropyl donor for synthesis of the essential polyamines spermidine and spermine (4). Transmethylation reactions result in the formation of S-adenosylhomocysteine which is then hydrolyzed by S-adenosylhomocysteine hydrolase to form adenosine and homocysteine. Decarboxylation of AdoMet is catalyzed by S-adenosylmethionine decarboxylase producing decarboxylated AdoMet, an intermediate committed to polyamine biosynthesis. Decarboxylated AdoMet donates an aminopropyl group to putrescine to form spermidine or to spermidine to form spermine. The end product of the aminopropyl transfer reactions is methylthioadenosine which is cleaved by a specific phosphorylase, the products being recycled in various ways to methionine and purines, respectively. A comprehensive review of polyamine metabolism and function has been published (3).

AdoMet is synthesized by AdoMet synthetase which transfers the adenosyl group of ATP to methionine with the residual triphosphate being hydrolyzed to P_i and PP_i by the polyphosphatase activity of AdoMet synthetase. To our knowledge, with the exception of mutants, no cell has previously been reported to lack this enzyme and AdoMet has not been known to be an essential nutrient. That AdoMet is an essential metabolite is shown by a mutant of Escherichia coli with very low AdoMet synthetase activity resulting in a cell division defect (4) and by knockout of this enzyme in Saccharomyces cerevisiae which is lethal but death can be prevented by exogenous AdoMet (5). Despite the universal activity of AdoMet synthetase, exogenous AdoMet can have an effect on wild type cells. For example, added AdoMet can stimulate budding and outgrowth as well as RNA and protein synthesis in S. cerevisiae (6). Another example is patients recovering from liver cirrhosis which results in low AdoMet synthetase activity; these patients are benefited by supplementing their diet with AdoMet (7, 8). Since AdoMet has been reported to enhance growth of another fungus (6), we added AdoMet to the medium we used to develop an axenic culture for P. carinii. This caused a qualitative and quantitative improvement in P. carinii culture including the production of cysts. Because of the positive effect of AdoMet on axenic culture of P. carinii culture and because analogues of AdoMet have been explored as pharmaceutical leads, we examined P. carinii for the possibility of an AdoMet requirement, for the ability to transport of AdoMet, for the rate of use of AdoMet and for the capacity to synthesize this essential intermediate. We found that P. carinii has a transport system for AdoMet which seems completely AdoMet-specific. We also found that P. carinii is an AdoMet auxotroph, a condition not previously reported for any cell.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Chemicals-- [methyl-¹⁴C]AdoMet was purchased from Moravek Biochemicals Inc. (Brea, CA). [methyl-¹⁴C]Methionine was from Amersham Life Science (Burkinghamshire, United Kingdom). Ultra-pure AdoMet was purchased from Research Biochemical International (Natick, MA). Putrescine, ferric pyrophosphate, L-cysteine, glutamine, L-methionine, ATP, hypoxanthine, adenine, di-sodium phosphate, monopotassium phosphate, sodium chloride, trisodium citrate, dithiothreitol, potassium chloride, S-adenosyl-L-homocysteine, dibutyl phthalate, acetonitrile, perchloric acid, heptane sulfonic acid, S-adenosyl-L-methionine, KCl, HEPES, MgSO₄, 1,7-diaminoheptane, and methylthioadenosine were from Sigma. AccQ.Fluor reagent kit was from Waters Corp. (Milford, MA).

Culture of P. carinii-- In vitro axenic culture of P. carinii was as described previously (9). Briefly, P. carinii cells were maintained in medium consisting of minimum essential medium with Earle's salts (Life Sciences, Grand Island, NY) supplemented with 20% horse serum (Life Sciences), and 80 µg ml¹ of each of the following: putrescine, ferric pyrophosphate, L-cysteine, and glutamine (PcMEM). Inocula (1.5 ml) containing 3 × 10⁶ cells ml¹ were placed in 24-mm collagen-coated, 0.4-µm membrane pore size Transwell^R inserts held in 6-well plates (Corning Costar Corp.). An additional 2.5 ml of medium was added to the wells below the inserts. The Transwell system allows changes of medium below the insert without disturbance of the cells within the inserts. The medium was changed twice daily and at each change freshly prepared 10 mM AdoMet stock solution was added to yield a final concentration of 500 µM. Cultures were incubated at 31 °C in room temperature. For counting, cells in the inserts were suspended by agitation and 10-µl samples were removed and diluted 10-fold with the following buffer: 58.5 mM disodium phosphate, 1.5 mM monopotassium phosphate, 43.5 mM NaCl, 10 mM trisodium citrate, 10 mM dithiothreitol, and 2.7 mM KCl, pH 7.4 (SPB). Citrate and dithiothreitol were included to help dissociate clumps of P. carinii thus facilitating counting Giemsa-stained smears as described previously (10). For some cultures growth was monitored by measuring total DNA in the culture as described (9).

Rat Model of PCP-- Rats were treated with antibiotics to limit other potential opportunistic infections, immunosuppressed then intratrachealy inoculated with P. carinii as described previously (11). Twenty-two days after inoculation, the rats were sacrificed. Lungs and blood were collected, processed, and P. carinii quantitated as described previously (12). The lungs and plasma were then stored in liquid nitrogen for up to 4 years. The thawed samples were analyzed for AdoMet content using a method depending on detection of a fluorescent adduct as described below.

Transport Measurement-- For uptake studies a previously published method (13) was modified. Cultured P. carinii cells were washed three times with MEM and resuspended in SPB at a density of approximately 7 × 10⁷ cells ml¹. Each assay had a final volume of 50 µl which included 45 µl of P. carinii cell suspension and an appropriate amount of [¹⁴CH₃]AdoMet supplemented with any other test compound in 5 µl of SPB buffer. After a suitable incubation time at 37 °C, [¹⁴CH₃]AdoMet remaining in the incubation medium was separated from the cells by microfuging through 100 µl of dibutyl phthalate and mineral oil (1:1). The supernatants were discarded and the cell pellets were collected and counted by liquid scintillation.

AdoMet Analysis-- A new method based on reverse phase ion-pair chromatography was developed for quantitation of AdoMet in P. carinii culture medium. An 80-µl medium sample from a P. carinii culture or control medium, held under the same conditions but without AdoMet or serum added, was mixed with 20 µl of 10% perchloric acid. After centrifugation at 5000 × g for 5 min to remove precipitated material, the supernatants were collected for HPLC assay. An internal standard, S-adenosyl ethionine (SAE), was added to all samples to a concentration of 13.9 µM. Chromatographic separation was achieved with an octyl silanol (C₈) reverse phase column (3.9 × 150 mm, Rainin Instrument Co., Woburn, MA) using an isocratic mobile phase of 40 mM ammonium phosphate, 8 mM heptane sulfonic acid (ion pairing reagent), and 3.6% acetonitrile (pH 5.0). The injection volume was 70 µl and the flow rate was 1.0 ml min¹. Absorbance was detected by a photodiode array (Waters 996) and recorded at 1-nm intervals from 200 to 500 nm. Chromatograms were extracted at 257 nm. Absorbance data at wavelengths other than 257 nm were used for Millennium^TM (Waters Corp., Milford, MA) software peak purity algorithms and for three-dimensional computer displays which were helpful for initial method development.

An alternative method was used for measuring AdoMet in rat plasma samples. AdoMet was extracted from plasma exactly as above. Pre-column derivitization was performed as described previously for polyamine analysis (14). An internal standard of 5 µl (5 µg ml¹ of 1,7-diaminoheptane) and 45 µl of borate buffer (0.2 M sodium borate, 1 mM EDTA, pH 8.8) was added to 30 µl of clarified plasma. After mixing, 20 µl of AccQ.Fluor reagent was added. HPLC conditions were as described previously for polyamine analysis (14). This method was calibrated and validated by demonstrating linearity (r > 0.99) and sensitivity in the subpicomole range using purchased authentic AdoMet.

Measurement of AdoMet Synthetase Activity-- Preparation of dialyzed P. carinii extract for enzymatic analysis was as described previously (15). Enzyme assay conditions were adapted from a published method (16). Enzymatically produced AdoMet was measured by HPLC with detection either by UV absorbance as described above or by measurement of radiolabeled methionine incorporated into AdoMet using a radioactivity detector with a 300-µl solid scintillant flow cell (Radiomatic Series A100, Packard Instruments, Downs Groove, IL). Rat liver extract was used as a known source of AdoMet to validate the enzyme assay. When UV detection was used, the final reaction mixture included 150 mM KCl, 2 mM dithiothreitol, 25 mM HEPES, 500 µM ATP, 5 mM MgSO₄, 1 mM methionine in a final volume of 200 µl of which 150 µl was crude dialyzed extract. Reactions were terminated by adding 40 µl of 10 N perchloric acid and placing the mixture on ice. When AdoMet was detected by radiolabel, the assay mixture was the same except that except that 400 µM [methyl-¹⁴C]methionine was used and the final volume of the reaction mixture was 100 µl of which 90 µl was the crude extract.

Protein Assay-- An aliquot of cells from each experiment was retained to determine protein concentration (dotMetric assay, Geno Technology, Inc., St. Louis, MO) and the remaining cells were used immediately for various experiments.

	RESULTS

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Utilization of AdoMet from the Medium-- Using authentic AdoMet, a novel HPLC analytical method based on UV absorbance was developed, calibrated, and validated. The assay was shown to be linear (r > 0.99) and sensitive to the picomole range (data not shown). Fig. 1 presents AdoMet decline in culture medium over 19 h with and without cells. The decline without cells is due to spontaneous degradation due to high pH (8.8-9.2) as previously reported (17). The greater decline in the presence of cells represents AdoMet utilization by P. carinii. Based on the 101 µM difference in AdoMet concentration after 8 h with 9.0 × 10⁶ P. carinii cells ml¹ and without cells, AdoMet usage calculates to be 1.40 × 10⁷ molecules cell¹ min¹.

View larger version (10K): [in this window] [in a new window]   Fig. 1.   Utilization of AdoMet by P. carinii in culture. The difference between medium with P. carinii and medium without represents AdoMet utilization by P. carinii. Data points are mean (±S.D.) from three independent experiments.

Effect of AdoMet on Growth of P. carinii-- Growth of P. carinii in culture with and without the addition of 500 µM AdoMet was followed for 27 days (Fig. 2A). After 15 days the number of cells in cultures without AdoMet began to decline and at 27 days they were only 22% of the number in cultures to which AdoMet had been added. This experiment was repeated (Fig. 2B) and the utilization of AdoMet was followed as the cell numbers increased. At each time point in Fig. 2B, the AdoMet content of the medium was measured at the time the cells were harvested for counting; these harvests were always 12 h after the addition of fresh medium and fresh AdoMet. The AdoMet remaining in the medium declined linearly with the increase in cell number (r > 0.90). Overall the pattern of growth is similar in Fig. 2, A and B, with the number of cells first increasing then declining in the cultures without AdoMet. Omission of AdoMet not only reduced the total number of P. carinii cells in culture but the cells were limited to small trophozoites rather than the mixture of small trophozoites, large trophozoites, and cysts seen in cultures grown with AdoMet or isolated from infected lungs (Giemsa-stained smears, data not shown). Since there was some P. carinii growth even without added AdoMet, we examined the possibility that this was dependent on AdoMet in the horse serum component of the medium. Two lots of horse serum were analyzed and the mean AdoMet content was 32 ± 2 µM. In two lots of fetal bovine serum, the serum supplement most commonly used for tissue culture medium, the mean AdoMet was 0.62 ± 0.15 µM. Growth of P. carinii was compared in media made with 20% dialyzed horse serum (Fig. 2C) and 20% fetal calf serum (Fig. 2D), both with and without the addition of AdoMet. Dialysis reduced the AdoMet content of horse serum to less than 2 nM. After 21 days in culture, the cells grown in media without additional AdoMet contained only 2% of the number of cells in media with added AdoMet. We also followed utilization of AdoMet from the media to which this metabolite was added and the AdoMet remaining at each time point was inversely linearly correlated with the number of cells in culture (r > 0.90).

View larger version (20K): [in this window] [in a new window]   Fig. 2.   Effect of AdoMet on P. carinii growth in medium containing horse serum, dialyzed horse serum, and fetal bovine serum. For panel A growth was monitored by counting cells in Giemsa-stained slides. For panels B, C, and D, growth was monitored by a DNA analysis method (9). The medium used for panels A and B used horse serum which has a relatively high natural AdoMet content (32 µM), panel C contained dialyzed horse serum (<2 nM AdoMet), and panel D, fetal calf serum which has a low content of AdoMet (0.62 µM AdoMet). The numbers on top of the curves in panels B, C, and D are AdoMet concentrations of the medium at the time the cells were harvested for counting; these harvests were always 12 h after the addition of fresh medium and AdoMet; the AdoMet remaining after 12 h declines as the number of P. carinii cells increases. Compared with growth in a medium containing horse serum which has a naturally high AdoMet content, the effect of the addition of AdoMet to the culture medium is greater when the serum component of the culture medium is either dialyzed horse serum or non-dialyzed fetal calf serum which has a lower AdoMet concentration than horse serum.

S-Adenosylmethionine Transport-- To determine the extent of AdoMet uptake, P. carinii cells were incubated for different times in SPB buffer containing 33 µM [¹⁴CH₃]AdoMet and AdoMet incorporated into the cells measured as described under "Experimental Procedures." The results shown in Fig. 3 indicate that, under these conditions, AdoMet accumulates in the cells reaching a maximal concentration at 2 min. To be sure that radioactivity measured in the cells represented AdoMet uptake rather than uptake of a breakdown product, P. carinii cells incubated with labeled AdoMet for 30 s were lysed and analyzed by HPLC. The only radioactive peak was at the AdoMet retention time confirming that the radioactivity measured in the cells pellets did represent transported AdoMet. Transport of AdoMet into P. carinii was measured over a range of pH values (4.0 to 8.5) using SPB buffer. Incubations were for 120 s and the [¹⁴CH₃]AdoMet concentration was 33 µM. Transport was pH dependent with a sharp optimum at pH 7.5. To determine transport kinetic constants, P. carinii cells were incubated for 30 s in the presence of various concentrations of [¹⁴CH₃]AdoMet. The Lineweaver-Burk plots shown in Fig. 4 indicate the presence of two transporters. For the high affinity transporter a K_m value (4.45 µM) was calculated and the extrapolated V_max value was 22 nmol min¹ mg of protein¹. For the low affinity transporter the K_m is 333 µM and the V_max 476 nmol min¹ mg of protein¹. Further studies were done with only the high affinity transporter because AdoMet concentrations in vivo are never high enough for the low affinity transporter to be physiologically relevant. This situation is similar to S. cerevisiae which has both a high and low affinity transporter (18). To detect whether AdoMet uptake was by facilitated diffusion or by active transport, inhibitors were used to block the production of ATP which would be required for active transport. The cytochrome inhibitor sodium azide (20 mM) reduced transport by 24 ± 4% (n = 3), however, the combination of the alternative oxidase inhibitor salicylhydroxamic acid (1 mM) and sodium azide (20 mM) reduced AdoMet transport by 95 ± 3% (n = 3). When cells were held on ice, uptake was 2% of that at 37 °C. Thus AdoMet is actively transported. Specificity of this AdoMet transporter was examined by testing the ability of compounds closely related to AdoMet to compete with AdoMet transport. The compounds listed in Table I were added to cell suspensions at the same 33 µM concentration as [¹⁴CH₃]AdoMet. The data show that none of these related compounds inhibited [¹⁴CH₃]AdoMet uptake. Unlabeled AdoMet did compete as expected.

View larger version (6K): [in this window] [in a new window]   Fig. 3.   Accumulation of AdoMet by P. carinii. Uptake was measured using AdoMet at 33 µM and conditions as described under "Results." Data points are mean (±S.D.) from three independent experiments. AdoMet accumulation is linear for 60 s.

View larger version (12K): [in this window] [in a new window]   Fig. 4.   Lineweaver-Burk plot of AdoMet transport. Incubations for transport were for 30 s and AdoMet concentrations ranged from 0.1 to 200 µM. The upper regression line in panel A was calculated from data points relevant to the high affinity transporter (2-15 µM AdoMet). The lower regression line in panel A is the same as the regression line in panel B and was calculated from data points relevant to the low affinity transporter (50-300 µM AdoMet).

AdoMet Biosynthesis-- The effect of exogenous AdoMet on growth of P. carinii in axenic culture and the existence of a specific AdoMet transporter suggested that P. carinii may not be able to synthesize AdoMet and thus be dependent on the host for this metabolite. For conclusive evidence, we examined P. carinii for the presence of AdoMet synthetase, the sole enzyme required for AdoMet biosynthesis from ATP and methionine. Rat liver homogenate supernatant was used as a known source of activity to validate the assay. UV detection of AdoMet and a 15-min reaction time were used. Using this assay, the activity of rat liver was 68.3 ± 7.5 pmol of AdoMet synthesized min¹ mg of protein¹, comparable to a reported value of 73.2 ± 9.6 pmol min¹ mg of protein¹ (19). P. carinii activity was below the detectable level of 1 pmol min¹ mg of protein¹. The assay was repeated with radiolabeled methionine using a reaction time increased to 30 min but this produced no radioactivity at the retention time for AdoMet (top panel of Fig. 5). To demonstrate the ability to detect very small amounts of radiolabeled AdoMet, 20 pmol of authentic radiolabeled AdoMet was added to the same incubation mixture producing the peak with a 15-min retention time seen in the bottom panel of Fig. 5. If an equal amount of liver homogenate had been used for the same incubation time, calculations indicate that 455 pmol of AdoMet would have been produced. Inspection of the chromatogram spiked with labeled AdoMet shows that this method could easily detect 0.5 pmol of AdoMet. Based on this, the AdoMet synthetase activity of P. carinii can be no more than 0.1% of that of rat liver, and we conclude that P. carinii has no AdoMet synthetase activity. We can eliminate the remote possibility that some AdoMet was produced by the P. carinii lysate but consumed by other reactions, therefore not detected. Such reactions would be either decarboxylation by AdoMet decarboxylase or loss of the radiolabeled methyl group by a methylation reaction. For the case of decarboxylation, the HPLC conditions used would have produced a peak of radioactivity at the retention time of 25 min but there was none (data not shown). Decarboxylated AdoMet cannot be metabolized further because dialysis removes the required aminopropyl acceptors. For the case of methylation reactions, small molecule methyl receptors were removed by dialysis of the extract. Large molecule methyl receptors would most likely have been precipitated by perchloric acid at the final 10% concentration and a check of the precipitate revealed no radioactivity. If large molecules were not precipitated, they would have remained in the extract applied to the HPLC column but the only radioactivity peaks were accounted for by the commercially supplied radiolabeled methionine. Extensive washing of the column eluted no additional radioactivity.

View larger version (25K): [in this window] [in a new window]   Fig. 5.   AdoMet synthetase activity in P. carinii. The top panel presents an radiolabel-based analysis of AdoMet present in an aliquot from a 30-min assay for AdoMet synthetase in a P. carinii homogenate. No AdoMet was detected. The bottom panel is an assay of another aliquot from the same assay except 20 pmol of radiolabeled AdoMet was added. The size of the 20-pmol peak demonstrates that as little as 0.5 pmol of AdoMet would have been easily detectable. These data indicate that P. carinii has no AdoMet synthetase activity.

AdoMet Use in Vivo-- Having shown that AdoMet is required by P. carinii and is depleted from culture medium, we considered the possibility that P. carinii might cause a reduction in the plasma AdoMet concentration in infected animals. Concentrations of most plasma components are held relatively constant by a negative feedback system but since individual cells all synthesize AdoMet, we thought it possible that AdoMet could be an exception so that an increase in utilization from the plasma would be reflected by a decrease in the plasma concentration. We were correct as shown in Fig. 6 which presents the plasma AdoMet concentrations of individual rats plotted against the number of P. carinii in the lungs. The negative relationship is striking. This result also indicates that the requirement for AdoMet is not a culture artifact.

View larger version (8K): [in this window] [in a new window]   Fig. 6.   AdoMet concentration in rat plasma versus PCP infection in the lungs. Rats with greater numbers of P. carinii in the lungs had markedly less AdoMet in their plasma. This decline in plasma AdoMet demonstrates that in vitro observations of exogenous AdoMet utilization by P. carinii are relevant in vivo.

	DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

AdoMet is an essential intermediate in the physiology of the cell, both for synthesis of polyamines and as a methyl donor for nearly all methylation reactions (3). To our knowledge, all cells investigated previously were found able to synthesize this intermediate from ATP and methionine using the enzyme AdoMet synthetase; AdoMet has never been described as an essential nutrient. To understand the reason underlying our previous observation that adding AdoMet to culture medium qualitatively promotes P. carinii growth (9) and to expand our general investigation of P. carinii polyamine metabolism (10, 15, 20, 21), we examined P. carinii both for the ability to utilize exogenous AdoMet and to synthesize this compound de novo. The results indicate that P. carinii has an absolute need for AdoMet and to date is the only cell known to be a natural AdoMet auxotroph.

The data reported here demonstrate the degree to which AdoMet both maintains and increases P. carinii growth in vitro. It is interesting to note that in the cultures with whole horse serum but without AdoMet, the initial growth followed by a slow decline is reminiscent of the growth in culture systems described prior to our recently published axenic system (9). Previous culture systems (22) utilized a mammalian feeder cell and very likely these cells provide a significant but limited amount of AdoMet. A similar role is played by the high concentration of AdoMet in horse serum relative to the more frequently used fetal calf serum. One could speculate that addition of AdoMet to a culture system using mammalian cells would allow continuous passage to fresh feeder cells. We were able to confirm AdoMet utilization by showing that P. carinii causes depletion of this metabolite from the growth medium and this is nicely supported by the in vivo data showing that P. carinii infection causes rat plasma to become depleted of AdoMet. Although our initial culture medium contained 500 µM AdoMet and this concentration was used for the studies reported here, we have found that 50 µM AdoMet is adequate to support growth. Starting at 50 µM, the spontaneous rate of AdoMet degradation in the medium predicts a decline to 14 µM or 5.6 µg ml¹ of medium at 12 h, somewhat less than reported AdoMet concentration in rat lungs, 11.1 µg g¹ of tissue (23). One could speculate that the now popular use of AdoMet as a nutritional supplement could result in increased vulnerability to infection with P. carinii but there is no direct data to support this.

Kinetics of AdoMet uptake indicate the presence of a transporter and the effect of metabolic inhibitors indicate that transport is an active, energy-requiring process. One of the most interesting kinetic findings was with natural compounds related to AdoMet none of which competed with AdoMet for transport. These compounds include: L-methionine and ATP (the components of AdoMet), hypoxanthine (a purine frequently scavenged by cells), adenine (the purine moiety of AdoMet), S-adenosylhomocysteine (AdoMet missing the S-methyl group), decarboxylated AdoMet (AdoMet missing the carboxyl group of methionine), methylthioadenosine (AdoMet after decarboxylation and donation of a propyl group), and S-adenosylethionine (an analogue with the S-methyl group substituted by an S-ethyl group). Therefore, it seems that the transporter recognizes neither any component of AdoMet nor any physiologically modified AdoMet suggesting that this transporter may recognize AdoMet alone. AdoMet transport by S. cerevisiae is similar to P. carinii in being facilitated by a high affinity transporter which is pH and energy dependent with a similar K_m (3.3 µM) (24). However, this S. cerevisiae transporter is not strictly AdoMet specific since both S-adenosylhomocysteine and S-adenosylethionine can compete with AdoMet although adenosine, methionine, and homocysteine do not (24). A recent study (18) reported an additional transport system in S. cerevisiae as well as cloning the originally described transporter. The originally described transporter is coded by the SAM3 gene and shows homology to the family of amino acid transporters. The newly described transporter is of low affinity (K_m = 160 µM), operates by facilitated diffusion and is not able to supply the needs of the cell fully, even at high concentrations of AdoMet. We also detected a second transport system in P. carinii but with a K_m = 330 µM it cannot be physiologically significant. It seems likely that the low affinity transporter activity is due to an entirely different transporter that will recognize AdoMet when it is at very high, non-physiological concentrations. The AdoMet transporter of African trypanosomes is as specific for AdoMet as the P. carinii transporter, although it operates by facilitated diffusion rather than active transport (25). In mammalian cells AdoMet penetrates poorly and extracellular AdoMet is mainly utilized to methylate phospholipids on the surface of plasma membrane (26).

The effect of metabolic inhibitors on AdoMet transport suggest that P. carinii utilizes both a cytochrome-mediated electron transport system and alternative oxidase-mediated system for energy production. Azide, which blocked transport by 24%, is a standard inhibitor of cytochrome-mediated ATP production. Salicylhydroxamic acid, which in combination with azide blocked transport by 95%, inhibits the enzyme alternative oxidase which provides a branch in electron transport at the level of ubiquinol. Although alternative oxidase itself does not lead to ATP generation by pumping protons, it does support transport of electrons to molecular oxygen, thus allowing ATP generation based on site 1 of oxidative phosphorylation as well as substrate level phosphorylation in the mitochondrion (27). Using an oxygen electrode, we have directly observed the ability of salicylhydroxamic acid to inhibit oxygen consumption (data not shown).

We conclude that P. carinii is an AdoMet auxotroph for the following reasons. AdoMet is necessary to support growth in vitro. P. carinii causes depletion of AdoMet from the culture medium. P. carinii has an AdoMet-specific transporter and no AdoMet synthetase activity. Strong evidence that these are not in vitro artifacts is provided by the finding that the concentration of AdoMet in rat plasma declines in proportion to the degree of P. carinii infection. An excellent chemotherapeutic opportunity is presented by this dependence of P. carinii on exogenous AdoMet and the presence of a specific transporter as well as the fact that mammalian cells do not transport AdoMet well. Although normal metabolites related to AdoMet do not inhibit transport, it may be possible to design analogues that are recognized by the transporter with equal or greater affinity than AdoMet. If transported in place of AdoMet, such compounds can also be expected to interfere with AdoMet-dependent methylation and with polyamine biosynthesis. This dual mode of action would be synergistic because suppression of AdoMet transport will increase the ratio of analogue to AdoMet within P. carinii thus enhancing the effect of the analogue on AdoMet utilizing enzymes. Because mammalian cells do not actively transport AdoMet, the chances of developing a compound with high specificity of P. carinii are good. Analogues of AdoMet have already been synthesized and considered as pharmaceutical leads for other infectious agents (28); a compound useful as an anti-P. carinii agent may be among these.

	FOOTNOTES

^* This work was supported in part by United States Public Health Service Grants R01 AI41947 and R01 AI43757.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Medical and Molecular Parasitology, New York University School of Medicine, 341 East 25^th St., New York, NY 10010. Tel.: 212-263-6956; Fax: 212-263-6956; E-mail: merals01@popmail.med.nyu.edu.

	ABBREVIATIONS

The abbreviations used are: PCP, Pneumocystis carinii pneumonia; HIV, human immunodeficiency virus; AdoMet, S-adenosyl-L-methionine; HPLC, high performance liquid chromatography.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				C. A. Moncada, A. Clarkson, O. Perez-leal, and S. Merali Mechanism and Tissue Specificity of Nicotine-mediated Lung S-Adenosylmethionine Reduction J. Biol. Chem., March 21, 2008; 283(12): 7690 - 7696. [Abstract] [Full Text] [PDF]

				G. Kutty, B. Hernandez-Novoa, M. Czapiga, and J. A. Kovacs Pneumocystis Encodes a Functional S-Adenosylmethionine Synthetase Gene Eukaryot. Cell, February 1, 2008; 7(2): 258 - 267. [Abstract] [Full Text] [PDF]

				S. Zheng, S. Shuman, and B. Schwer Sinefungin resistance of Saccharomyces cerevisiae arising from sam3 mutations that inactivate the AdoMet transporter or from increased expression of AdoMet synthase plus mRNA cap guanine-N7 methyltransferase Nucleic Acids Res., November 29, 2007; 35(20): 6895 - 6903. [Abstract] [Full Text] [PDF]

				A. K. Greenberg, B. Rimal, K. Felner, S. Zafar, J. Hung, E. Eylers, B. Phalan, M. Zhang, J. D. Goldberg, B. Crawford, et al. S-Adenosylmethionine as a Biomarker for the Early Detection of Lung Cancer Chest, October 1, 2007; 132(4): 1247 - 1252. [Abstract] [Full Text] [PDF]

				M. Shivji, S. Burger, C. A. Moncada, A. B. Clarkson Jr., and S. Merali Effect of Nicotine on Lung S-Adenosylmethionine and Development of Pneumocystis Pneumonia J. Biol. Chem., April 15, 2005; 280(15): 15219 - 15228. [Abstract] [Full Text] [PDF]

				Z. Song, S. Barve, T. Chen, W. Nelson, S. Uriarte, D. Hill, and C. McClain S-adenosylmethionine (AdoMet) modulates endotoxin stimulated interleukin-10 production in monocytes Am J Physiol Gastrointest Liver Physiol, June 1, 2003; 284(6): G949 - G955. [Abstract] [Full Text] [PDF]

				A. M. Tucker, H. H. Winkler, L. O. Driskell, and D. O. Wood S-Adenosylmethionine Transport in Rickettsia prowazekii J. Bacteriol., May 15, 2003; 185(10): 3031 - 3035. [Abstract] [Full Text] [PDF]

				H. H. Larsen, J. A. Kovacs, F. Stock, V. H. Vestereng, B. Lundgren, S. H. Fischer, and V. J. Gill Development of a Rapid Real-Time PCR Assay for Quantitation of Pneumocystis carinii f. sp. carinii J. Clin. Microbiol., August 1, 2002; 40(8): 2989 - 2993. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Merali, S. Articles by Clarkson, A. B. Search for Related Content PubMed PubMed Citation Articles by Merali, S. Articles by Clarkson, A. B., Jr. Social Bookmarking                      What's this?